ADAMTS13 antibody | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

12,548 results for “ADAMTS13 antibody”

Trials

View all 4723 →

ADAMTS13 in Thrombotic Thrombocytopenic Purpura

153 participants · First posted Jan 25, 2007

A Survey of Recombinant ADAMTS13 in Participants With Congenital Thrombotic Thrombocytopenic Purpura

40 participants · First posted Jun 4, 2024

Phase 1 Dose Escalation, Single Dose Study to Assess Safety and Pharmacokinetics of BAX930 in Hereditary Thrombotic Thrombocytopenic Purpura (TTP)

16 participants · First posted Aug 13, 2014

Drugs

View all 2104 →

antibody

neutralizing antibody

Investigational

NVS antibody

Organizations

View all 54 →

Cambridge Antibody Technology

New Zealand

Latticon Antibody Therapeutics, Inc

United States

Compass Therapeutics

United States

News

View all 5667 →

KU Leuven Spin-off Hemastatx Develops First Therapy Targeting Root Cause of Severe Bleeding Disorder

FDA Investigates Fatal Adverse Event Linked to Takeda's Adzynma Enzyme Replacement Therapy

FDA Approves Takeda's Adzynma as First Treatment for Ultra-Rare Blood Clotting Disorder cTTP

Page 1 of 1255